Shortcuts

open access

Vol 15, No 1 (2017)
Prace poglądowe (nadesłane)
Get Citation

Wulwodynia ― stan wiedzy na 2017 rok

Ewa Baszak-Radomańska, Marek Jantos
Seksuologia Polska 2017;15(1).

open access

Vol 15, No 1 (2017)
Prace poglądowe (nadesłane)

Abstract

Vulvodynia remains the most neglected women’s health problem. According to its definition it can be perceived as a pain, most often described as burning, rawness, itchiness, vulvar hypersensitivity to pressure and dryness. Pain can extend to the perineum and anal area, and is of at least 3 months duration. Vulvodynia is a disorder diagnosed on the basis of exclusion of any clinically identifiable causes. In most cases it is treated as a form of peripheral, localized neuropathic pain, shown to be associated with pelvic muscle and fascial dysfunction. The etiology is thought to be multifactorial and a specific cause it is difficult to identify. In general, therapy is individualized and multidisciplinary.

In cases where pain is experienced during sexual intercourse (dyspareunia), with no obvious pathology as the cause of pain, it is classified as provoked vulvodynia.

Chronic pain is a significant health issues and requires treatment. Appropriate interventions are a health priority. The worldwide prevalence of vulvodynia ranges from 5–16% of women. In-spite of its high incidence confirmation of the diagnoses is often delayed and inconclusive and the treatment interventions are ineffective. This article provides an update on the current understanding of the disorder while recognizing the ever-expanding knowledge base and need for further research and insight.

Abstract

Vulvodynia remains the most neglected women’s health problem. According to its definition it can be perceived as a pain, most often described as burning, rawness, itchiness, vulvar hypersensitivity to pressure and dryness. Pain can extend to the perineum and anal area, and is of at least 3 months duration. Vulvodynia is a disorder diagnosed on the basis of exclusion of any clinically identifiable causes. In most cases it is treated as a form of peripheral, localized neuropathic pain, shown to be associated with pelvic muscle and fascial dysfunction. The etiology is thought to be multifactorial and a specific cause it is difficult to identify. In general, therapy is individualized and multidisciplinary.

In cases where pain is experienced during sexual intercourse (dyspareunia), with no obvious pathology as the cause of pain, it is classified as provoked vulvodynia.

Chronic pain is a significant health issues and requires treatment. Appropriate interventions are a health priority. The worldwide prevalence of vulvodynia ranges from 5–16% of women. In-spite of its high incidence confirmation of the diagnoses is often delayed and inconclusive and the treatment interventions are ineffective. This article provides an update on the current understanding of the disorder while recognizing the ever-expanding knowledge base and need for further research and insight.

Get Citation

Keywords

vulvodynia, dyspareunia, pelvic floor muscle therapy, vulvar pain, painful sex, chronic urogenital pain

About this article
Title

Wulwodynia ― stan wiedzy na 2017 rok

Journal

Seksuologia Polska (Polish Sexology)

Issue

Vol 15, No 1 (2017)

Bibliographic record

Seksuologia Polska 2017;15(1).

Keywords

vulvodynia
dyspareunia
pelvic floor muscle therapy
vulvar pain
painful sex
chronic urogenital pain

Authors

Ewa Baszak-Radomańska
Marek Jantos

References (23)
  1. Nunns D, Mandal D, Byrne M, et al. British Society for the Study of Vulval Disease (BSSVD) Guideline Group. Guidelines for the management of vulvodynia. Br J Dermatol. 2010; 162(6): 1180–1185.
  2. Persistent Vulvar Pain; Committee Opinion No. 673. American College of obstericians and ginecologists. Obstetricians and Gynecologists Obstet Gynecol. 2016.
  3. Andrews JC, Bogliatto F, Lawson HW, et al. Speaking the Same Language: Using Standardized Terminology. J Low Genit Tract Dis. 2016; 20(1): 8–10.
  4. Goldstein AT, Pukall CF, Brown C, et al. Vulvodynia: Assessment and Treatment. J Sex Med. 2016; 13(4): 572–590.
  5. Pukall CF, Goldstein AT, Bergeron S, et al. Vulvodynia: Definition, Prevalence, Impact, and Pathophysiological Factors. J Sex Med. 2016; 13(3): 291–304.
  6. Havemann LM, Cool DR, Gagneux P, et al. Vulvodynia: What We Know and Where We Should Be Going. J Low Genit Tract Dis. 2017; 21(2): 150–156.
  7. Arnold LD, Bachmann GA, Rosen R, et al. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol. 2006; 107(3): 617–624.
  8. Bonham A. Vulvar vestibulodynia: strategies to meet the challenge. Obstet Gynecol Surv. 2015; 70(4): 274–278.
  9. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007; 117(2): 289–296.
  10. Jantos M, Johns S, Torres A, et al. Mapping chronic urogenital pain in women: review and rationale for a muscle assessment protocol – Part 1. Pelviperineology. 2015; 34: 21–27.
  11. Curran N. xxxxxxxxxxxxxxxxxxxxxxxx. Reviews in Pain. 2008; 2(2): 25–28.
  12. Jantos M, Burns NR. Vulvodynia. Development of a psychosexual profile. J Reprod Med. 2007; 52(1): 63–71.
  13. Rodzaje bólu. http://www.mp.pl/bol/wytyczne/94188,rodzaje-bolu. (1.10.2014).
  14. Rao SSC, Patcharatrakul T. Diagnosis and Treatment of Dyssynergic Defecation. J Neurogastroenterol Motil. 2016; 22(3): 423–435.
  15. Dargie E, Holden RR, Pukall CF. The Vulvar Pain Assessment Questionnaire inventory. Pain. 2016; 157(12): 2672–2686.
  16. Friedrich EG. Vulvar vestibulitis syndrome. J Repr Med. 1987; 32: 110–114.
  17. Reed B, Plegue M, Harlow S, et al. Does Degree of Vulvar Sensitivity Predict Vulvodynia Characteristics and Prognosis? The Journal of Pain. 2017; 18(2): 113–123.
  18. Prendergast SA, Weiss JM. Screening for musculoskeletal causes of pelvic pain. Clin Obstet Gynecol. 2003; 46(4): 773–782.
  19. Hartmann D, Sarton J. Chronic pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol. 2014; 28(7): 977–990.
  20. Bogliatto F, Boraso F. A New Model of Care: The Lower Female Anourogenital Network. J Low Genit Tract Dis. 2016; 20(1): 105–106.
  21. Gentilcore-Saulnier E, McLean L, Goldfinger C, et al. Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program. J Sex Med. 2010; 7(2 Pt 2): 1003–1022.
  22. Kocot-Kępska M, Przeklasa-Muszyńska A, Kołłątaj M. Niefarmakologiczne metody leczenia bólu przewlekłego. Terapia. 2010; 11-12: 20–25.
  23. Chisari C, Chilcot J. The experience of pain severity and pain interference in vulvodynia patients: The role of cognitive-behavioural factors, psychological distress and fatigue. J Psychosom Res. 2017; 93: 83–89.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl